S1P Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

S1P Therapeutics General Information

Description

Developer of Spns2 inhibitors designed for the treatment of fibrotic and autoimmune diseases. The company's platform disrupts the production of sphingosine-1-phosphate, a key signaling molecule involved in both inflammatory processes and fibrosis development, improving patient outcomes in areas with significant unmet medical needs.

Contact Information

Website
www.s1ptx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2200 Kraft Drive South West
  • Suite 1050
  • Blacksburg, VA 24060
  • United States
+1 (703)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2200 Kraft Drive South West
  • Suite 1050
  • Blacksburg, VA 24060
  • United States
+1 (703)

S1P Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

S1P Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Jan-2026 Completed Startup
3. Grant 04-Mar-2025 Completed Startup
2. Grant 14-Dec-2023 $600K $2.02M Completed Startup
1. Seed Round 09-Jun-2023 $2.02M $2.02M Completed Startup
To view S1P Therapeutics’s complete valuation and funding history, request access »

S1P Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view S1P Therapeutics’s complete cap table history, request access »

S1P Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

S1P Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Regional Accelerator & Mentoring Program Accelerator/Incubator
Virginia Catalyst University
Virginia Innovation Partnership Corporation Not-For-Profit Venture Capital
To view S1P Therapeutics’s complete investors history, request access »

S1P Therapeutics FAQs

  • When was S1P Therapeutics founded?

    S1P Therapeutics was founded in 2019.

  • Where is S1P Therapeutics headquartered?

    S1P Therapeutics is headquartered in Blacksburg, VA.

  • What is the size of S1P Therapeutics?

    S1P Therapeutics has 4 total employees.

  • What industry is S1P Therapeutics in?

    S1P Therapeutics’s primary industry is Drug Discovery.

  • Is S1P Therapeutics a private or public company?

    S1P Therapeutics is a Private company.

  • What is S1P Therapeutics’s current revenue?

    The current revenue for S1P Therapeutics is .

  • How much funding has S1P Therapeutics raised over time?

    S1P Therapeutics has raised $2.02M.

  • Who are S1P Therapeutics’s investors?

    Regional Accelerator & Mentoring Program, Virginia Catalyst, and Virginia Innovation Partnership Corporation have invested in S1P Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process